Expanded Scope of Clinical Validation Study Will Provide Access to a Broader Patient Population Company Expects to File 510K No Later Than August 15, 2022 SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today that HeartBeam is expanding the … [Read more…]

SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop … [Read more…]

Nina Agdal, Joe Holder and More to Join AG1 Team for Weekend Wellness Events at Montauk, NY Resort NEW YORK–(BUSINESS WIRE)–Athletic Greens, originators of the Foundational Nutrition category and creators of the daily nutrition drink AG1, announced today its partnership with The Surf Lodge, a hotel, restaurant and bar in Montauk, New York, for a … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Infrared Thermometers – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Infrared Thermometers Market to Reach $1.3 Billion by 2026 Amid the COVID-19 crisis, the global market for Infrared Thermometers estimated at US$752.5 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion … [Read more…]

The Newly Launched MamaLift Program Provides Mental Health Support for Expecting and New Mothers Across Multiple States PRINCETON, N.J.–(BUSINESS WIRE)–Curio Digital Therapeutics and Axia Women’s Health, one of the nation’s largest independent women’s health groups, are pleased to announce a collaboration agreement to help women at risk for postpartum depression and those diagnosed with postpartum … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it has entered into securities purchase agreements with new and existing investors and certain directors and officers in a registered direct offering of 31,746,030 shares of common stock (the “Shares”) at a purchase price of $3.15 per share, resulting in … [Read more…]

Leading Intensive Care Clinical Decision-Support Software and Acute Care Diagnostics Medical Device Provider Announce Partnership BOSTON & BREA, Calif.–(BUSINESS WIRE)–#Etiometry—Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, today announced a new collaboration to enhance the clinical workflows in Neonatal Intensive … [Read more…]

HUNTSVILLE, Ala.–(BUSINESS WIRE)–#diagnostics–Madison Core Laboratories, LLC (MCL) announces the appointment of Jerry C. Smith, a seasoned financial executive, as Chief Financial Officer (“CFO”). Smith brings to MCL a CPA background and over 25 years of experience in finance, accounting, revenue cycle management, and mergers and acquisitions in multiple sectors of healthcare and technology. He most … [Read more…]

IPF study will evaluate efficacy of two doses of LYT-100, one with comparable exposure to FDA-approved dose of pirfenidone and one with higher exposure, vs. placebo, as well as relative tolerability and efficacy vs. pirfenidone Bi-monthly, monotherapy dose escalation portion of Phase 1/2 study of LYT-200 for the potential treatment of solid tumors has completed; … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for belzupacap sarotalocan (AU-011), Aura’s first VDC product candidate, for the treatment of Non-Muscle Invasive … [Read more…]